Articles

G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025

While there’s no denying that G1 Therapeutics stock is highly speculative, investors should still check under the hood. More 

Buy Alert: 3 Best Stocks to Scoop Up Near 52-Week Lows

Seize the opportunity with these stocks near 52-week lows, offering superb returns while being backed by strong fundamentals. More 

RCRT Stock Earnings: Recruiter.Com Group Beats Revenue for Q4 2023

RCRT stock results show that Recruiter.Com Group beat on revenue for the fourth quarter of 2023. More 

QIWI Stock Earnings: QIWI Reported Results for Q4 2023

QIWI just reported results for the fourth quarter of 2023. More 

QEPC Stock Earnings: Q.E.P. Reported Results for Q4 2024

Q.E.P. just reported results for the fourth quarter of 2024. More 

Why Is Autonomix Medical (AMIX) Stock Up 120% Today?

A licensing agreement brings credibility and opportunity for Autonomix Medical, sending AMIX stock soaring despite a risky profile. More 

Wedbush Is Betting Big on Palantir (PLTR) Stock Ahead of Q2 Earnings

Palantir Technologies is up today after one analyst named it as a likely Q2 winner. Here's why he thinks PLTR stock can keep rising. More